Rönnlund, Caroline
Sifakis, Emmanouil G.
Schagerholm, Caroline
Yang, Qiao
Karlsson, Emelie
Chen, Xinsong
Foukakis, Theodoros
Weidler, Jodi
Bates, Michael
Fredriksson, Irma
Robertson, Stephanie
Hartman, Johan
Funding for this research was provided by:
Region Stockholm
Cepheid, Sunnyvale, CA, USA
The Swedish Cancer Society
MedTechLabs
The Cancer Society in Stockholm
The Swedish Breast Cancer Association
The Swedish Society for Medical Research
Roche, Rotkreutz, Switzerland
Karolinska Institute
Article History
Received: 24 November 2023
Accepted: 24 January 2024
First Online: 7 February 2024
Declarations
:
: This study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the Regional Ethical Review Board in Stockholm. No additional informed consent was required in accordance with ethical approval in this non-interventional data collection and analysis.
: Not applicable.
: J.H. has obtained speaker's honoraria or advisory board remunerations from Roche, Novartis, AstraZeneca, Pfizer, Eli Lilly, MSD and Gilead and has received institutional research support from Cepheid, Roche, Novartis and AstraZeneca. J.H. is a co-founder and shareholder of Stratipath AB. T.F. has obtained speaker's honoraria or advisory board remunerations from Astra Zeneca, Roche, Gilead, Affibody, Pfizer, Exact Sciences, Novartis and Veracyte and has received institutional research support from Astra Zeneca, Novartis, Roche and Pfizer and author royalties from UpToDate. I.F. has received institutional research support from MSD. S.R. is an employee and holds stock options of Stratipath AB. J.W. and M.B. are full-time employees of Cepheid and own stock in Danaher, Inc. All other authors have no disclosures to declare.